Department Of Medicine 17
801. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
802. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
803. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
804. A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema
805. A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema
806. Diagnosis and classification of optic neuritis
807. The story of critical care in Asia: a narrative review
808. Autoimmune pancreatitis and pancreatic cancer: Epidemiological aspects and immunological considerations
809. Basophils in autoimmunity: Systemic lupus erythematosus and more?
810. Celiac Disease and Gallbladder: Pathophysiological Aspects and Clinical Issues
811. Celiac Disease in Asia beyond the Middle East and Indian subcontinent: Epidemiological burden and diagnostic barriers
812. Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders
813. Conventional and novel therapeutic options in children with familial Mediterranean fever: A rare autoinflammatory disease
814. Double-negative T cells in pediatric rheumatic diseases
815. Editorial: COVID-19 and hyper inflammation syndrome: Different presentation and management
816. HLA-B*51 allelic and carrier frequency in Kazakhstan: insights into Behçet’s disease prevalence in Central Asia
817. Impact of Anti-Type 2 Inflammation Biologic Therapy on COVID-19 Clinical Course and Outcome
818. Implementing a Pediatric Residency Program in Central Asia in Compliance with ACGME-International Standards: First Experience from Kazakhstan
819. Infantile giant cell hepatitis with autoimmune hemolytic anemia
820. Mycoplasma pneumoniae Infections and Primary Immune Deficiencies
821. Mycoplasma pneumoniae Seroprevalence and Total IgE Levels in Patients with Juvenile Idiopathic Arthritis
822. Pediatric erythema ab igne: clinical aspects and diagnostic issues
823. Salivary Microbiome in Pediatric and Adult Celiac Disease
824. Cannabis Use and Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease Transitioning to Dialysis
825. Neurological, cardiac, musculoskeletal, and renal manifestations of scleroderma along with insights into its genetics, pathophysiology, diagnostic, and therapeutic updates
826. Epidemiology, detection, diagnosis and treatment of TB in children in Kazakhstan
827. Capacity for the management of kidney failure in the International Society of Nephrology Newly Independent States and Russia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
828. Capacity for the management of kidney failure in the International Society of Nephrology Newly Independent States and Russia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)
829. Preloaded combination nicotine replacement therapy for smoking cessation in Kazakhstan: A randomized controlled trial study protocol
830. Mortality predictors of hospitalized patients with COVID-19: Retrospective cohort study from Nur-Sultan, Kazakhstan
831. Survival disparities and predictors in gastric cancer: a population-based study from Kazakhstan (2012–2023)
832. Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC
833. Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC
834. GWAS meta-analysis identifies five susceptibility loci for endometrial cancer
835. Human Immunodeficiency Virus Type-1 Genetic Diversity and Drugs Resistance Mutations among People Living with HIV in Karachi, Pakistan
836. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
837. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
838. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
839. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
840. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
841. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
842. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
843. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
844. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
845. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
846. Magnolol and its semi-synthetic derivatives: a comprehensive review of anti-cancer mechanisms, pharmacokinetics, and future therapeutic potential
847. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
848. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
849. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
850. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
1 15 16 17 18 19 24